Log in Remember me (Uncheck if on a shared computer) Forgot your Password ? Please review the fields marked in red and resubmit the form Create an account Register to access independent medical news and resources from Univadis®
Medical News European Commission to reward projects that help modernise health services Univadis Medical News 22 February 2019 The European Commission has launched the 2019 REGIOSTARS Awards this week. Global health spending on the rise - WHO report Univadis Medical News 22 February 2019 New data suggest more than half of health spending in low- and middle-income countries is devoted to primary health care. Hepatocellular cancer: ESMO updates treatment guidance Univadis Medical News 22 February 2019 Updated ESMO guideline on the treatment of hepatocellular cancer now includes lenvatinib and cabozantinib. More Medical News > Conference Reports ASCO-GU 2019—Adjuvant chemotherapy + postop radiotherapy improves DFS, OS in locally advanced urothelial carcinoma Univadis 19 February 2019 Post-hoc analysis of phase 3 trial results. ASCO-GU 2019—Avelumab+axitinib bests sunitinib in previously untreated clear-cell aRCC Univadis 19 February 2019 Results from the ongoing JAVELIN Renal 101 phase 3 trial. ASCO-GU 2019—Darolutamide improves MFS in castration-resistant prostate cancer Univadis 19 February 2019 Darolutamide may offer an alternative to apalutamide and enzalutamide. More Conference Reports >
Medical News European Commission to reward projects that help modernise health services Univadis Medical News 22 February 2019 The European Commission has launched the 2019 REGIOSTARS Awards this week. Global health spending on the rise - WHO report Univadis Medical News 22 February 2019 New data suggest more than half of health spending in low- and middle-income countries is devoted to primary health care. Hepatocellular cancer: ESMO updates treatment guidance Univadis Medical News 22 February 2019 Updated ESMO guideline on the treatment of hepatocellular cancer now includes lenvatinib and cabozantinib. More Medical News >
Conference Reports ASCO-GU 2019—Adjuvant chemotherapy + postop radiotherapy improves DFS, OS in locally advanced urothelial carcinoma Univadis 19 February 2019 Post-hoc analysis of phase 3 trial results. ASCO-GU 2019—Avelumab+axitinib bests sunitinib in previously untreated clear-cell aRCC Univadis 19 February 2019 Results from the ongoing JAVELIN Renal 101 phase 3 trial. ASCO-GU 2019—Darolutamide improves MFS in castration-resistant prostate cancer Univadis 19 February 2019 Darolutamide may offer an alternative to apalutamide and enzalutamide. More Conference Reports >
Featured Channels Oncology Oncology essentials all in one place Zika All you need to know about Zika virus